Pivotal pharmacodynamic equivalence trial of Captisol-enabled intravenous clopidogrel.
Phase of Trial: Phase III
Latest Information Update: 25 Oct 2012
At a glance
- Drugs Clopidogrel (Primary) ; Clopidogrel (Primary)
- Indications Coronary thrombosis
- Focus Registrational; Therapeutic Use
- Sponsors Ligand Pharmaceuticals
- 25 Oct 2012 Status changed from planning to recruiting, as reported in a Medicines Company media release.
- 09 Feb 2012 New trial record